Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

P Kong, ZY Cui, XF Huang, DD Zhang… - Signal transduction and …, 2022 - nature.com
Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and
nontraditional risk factors. Genome-wide association combined with clonal lineage tracing …

Vascular mechanotransduction

MJ Davis, S Earley, YS Li, S Chien - Physiological reviews, 2023 - journals.physiology.org
This review aims to survey the current state of mechanotransduction in vascular smooth
muscle cells (VSMCs) and endothelial cells (ECs), including their sensing of mechanical …

Vascular smooth muscle cells in atherosclerosis

GL Basatemur, HF Jørgensen, MCH Clarke… - Nature reviews …, 2019 - nature.com
Vascular smooth muscle cells (VSMCs) are a major cell type present at all stages of an
atherosclerotic plaque. According to the 'response to injury'and 'vulnerable …

Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels

L Dobnikar, AL Taylor, J Chappell, P Oldach… - Nature …, 2018 - nature.com
Vascular smooth muscle cells (VSMCs) show pronounced heterogeneity across and within
vascular beds, with direct implications for their function in injury response and …

The corticotropin-releasing factor family: physiology of the stress response

JM Deussing, A Chen - Physiological reviews, 2018 - journals.physiology.org
The physiological stress response is responsible for the maintenance of homeostasis in the
presence of real or perceived challenges. In this function, the brain activates adaptive …

An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis

F Zhang, X Guo, Y Xia, L Mao - Cellular and Molecular Life Sciences, 2022 - Springer
Vascular smooth muscle cells (VSMCs) are involved in phenotypic switching in
atherosclerosis. This switching is characterized by VSMC dedifferentiation, migration, and …

More than just a monolayer: the multifaceted role of endothelial cells in the pathophysiology of atherosclerosis

M Mussbacher, K Schossleitner… - Current atherosclerosis …, 2022 - Springer
Abstract Purpose of the Review In this review, we summarize current insights into the
versatile roles of endothelial cells in atherogenesis. Recent Findings The vascular …

GLP-1 receptor expression within the human heart

LL Baggio, B Yusta, EE Mulvihill, X Cao… - …, 2018 - academic.oup.com
Abstract Glucagonlike peptide-1 receptor (GLP-1R) agonists, which are used to treat type 2
diabetes and obesity, reduce the rates of myocardial infarction and cardiovascular death …

GPCRomics: an approach to discover GPCR drug targets

PA Insel, K Sriram, MW Gorr, SZ Wiley… - Trends in …, 2019 - cell.com
G protein-coupled receptors (GPCRs) are targets for∼ 35% of approved drugs but only∼
15% of the∼ 800 human GPCRs are currently such targets. GPCRomics, the use of …

Mutations in G protein–coupled receptors: mechanisms, pathophysiology and potential therapeutic approaches

T Schöneberg, I Liebscher, P Insel - Pharmacological reviews, 2021 - Elsevier
There are approximately 800 annotated G protein–coupled receptor (GPCR) genes, making
these membrane receptors members of the most abundant gene family in the human …